iOS app Android app

Votrient

FDA Panel Backs Rare Sarcoma Cancer Drug

AP | MATTHEW PERRONE | Posted 05.20.2012 | Healthy Living

WASHINGTON — A panel of cancer experts rejected an experimental Merck drug for a rare form of cancer on Tuesday while recommending approval of a...